T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT02133196 · RECRUITING
Trial details
- NCT number
- NCT02133196
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-23
- Primary completion
- 2027-10-23
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.